How will the formation of the Common Free Market Zone affect the pharmaceutical industry?
The formation of the Common Free Market Zone is one of the most vital topics of the Russian market today. Projects of such scale always affect all the industry spheres and require common standards and rules. Pharmaceutical industry is no exception. In order to discuss the state and prospects of current industry requirements the Association of Russian Pharmaceutical Associations invites the guests to take part in one of the International Medical and Pharmaceutical Business Forum’s workshops –“Pharmaceutical production in the period of common economic space formation”, which will take place December 3.
Following topics will be discussed:
- GMP inspection. Status and perspectives. Ivan Glushkov, Director of the External Affairs Department of “STADA CIS”
- Countermeasures against the counterfeit medicine trade in the context of “Medicrim”.Eugeny Kardash, Director of Economic Security of “Polysan”
- The report’s topic will be specified later. Vladimir Razumov, Manager of State Authorities Relations of “Pertovaks Pharm”
- Harmonization of the demands to post-graduate specialists’ training in pharmaceutical sphere in the period of common economic space formation. Rimma Abramovich, Director of the Scientific and Research Centre of the Russian University of Peoples Friendship
Moderator: Victor Dmitriev, General Director of the Association of Russian Pharmaceutical Manufacturers
The business event will take place December, 3rd, at Expocentre, Pavillion #3 in the Conference Hall #2, from 14.00 to 16.00 p.m.
The Forum and Conference are free. Please register at http://www.aptekaexpo.com/visit/ticket.php
Dates and venue:
December 3-5, 2012
Moscow, CEC Expocentre, Pavillion # 3